Sabin Executive Vice President Dr. Ciro de Quadros attended this week’s Pacific Health Summit in Seattle, Washington. The theme of the 2011 conference was vaccines.
A key message in our Sustainable Immunization Financing (SIF) Program work is that countries need to reduce their dependencies by appropriating their routine immunization programs.
In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.